People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...
People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...
6don MSN
Minimally invasive procedure for aortic valve disease has similar outcomes as surgery, study reports
People who underwent a minimally invasive procedure to have their heart's aortic valve replaced had similar health outcomes ...
PARADIGM: A Prospective rAndomized tRial Assessing the safety and effectiveness of the DurAVR® bIomimetic valve designed for physioloGic flow compared to CoMmercial TAVR devices MINNEAPOLIS and ...
The Central Chest Institute of Thailand (CCIT) in Nonthaburi has adopted the Tavi procedure to treat aortic valve stenosis, a ...
GlobalData on MSN
Edwards solidifies TAVR dominance in long-term trial readout
The respective readouts demonstrated TAVR’s comparable performance to surgical aortic valve replacement treatment.
A troubling rise in severe diverticulitis cases among Americans under 50 highlights a significant public health concern.
Anteris Technologies (Nasdaq:AVR) today announced one-year clinical outcomes for its DurAVR transcatheter heart valve (THV).
Anteris Technologies has won FDA approval to conduct a key clinical trial for its heart valve device in the US.
Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical ...
Medpage Today on MSN
First 7-Year Report of Low-Risk TAVR Reassures, With Finish Line Now in Sight
SAN FRANCISCO -- Long-term outcomes after transcatheter aortic valve replacement (TAVR) were looking more and more like those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback